CEFEPIMA MIP 2g powder for injection / infusion solution medication leaflet

J01DE01 cefepime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Fourth-generation cephalosporins

Cefepime is a fourth-generation cephalosporin antibiotic used to treat severe bacterial infections, including pneumonia, intra-abdominal infections, urinary tract infections, and sepsis. It is effective against a wide range of gram-positive and gram-negative bacteria, including Pseudomonas aeruginosa.

The medication is administered intravenously or intramuscularly, and the dosage is adjusted based on the severity of the infection, the patient's weight, and renal function. Cefepime is often used in hospitals for complicated infections or for patients at high risk of severe infections.

Patients should be closely monitored during treatment to detect potential side effects, such as allergic reactions, diarrhea, or renal toxicity. It is important for patients to complete the treatment as directed by their doctor.

Side effects may include nausea, diarrhea, skin rashes, or, in rare cases, severe reactions such as encephalopathy or seizures. Patients should inform their doctor of any unusual symptoms.

General data about CEFEPIMA MIP 2g

Substance: cefepime

Date of last drug list: 01-06-2025

Commercial code: W61587003

Concentration: 2g

Pharmaceutical form: powder for injection / infusion solution

Quantity: 10

Product type: generic

Price: 582.87 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MIP PHARMA GMBH - GERMANIA

Holder: MIP PHARMA GMBH - GERMANIA

Number: 11930/2019/03

Shelf life: 27 months-After packaging for sale;After first opening the bottle.: 2 h la temp. de 25°C

Pharmaceutical forms available for cefepime

Concentrations available for cefepime

1g, 2g

Other substances similar to cefepime